These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18249302)

  • 1. Transglutaminase and the pathogenesis of coeliac disease.
    Stenberg P; Roth EB; Sjöberg K
    Eur J Intern Med; 2008 Mar; 19(2):83-91. PubMed ID: 18249302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidylarginine deiminases and the pathogenesis of rheumatoid arthritis: a reflection of the involvement of transglutaminase in coeliac disease.
    Stenberg P; Roth B; Wollheim FA
    Eur J Intern Med; 2009 Dec; 20(8):749-55. PubMed ID: 19892302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
    Dørum S; Qiao SW; Sollid LM; Fleckenstein B
    J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.
    Skovbjerg H; Norén O; Anthonsen D; Moller J; Sjöström H
    Scand J Gastroenterol; 2002 Jul; 37(7):812-7. PubMed ID: 12190095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase 2 in celiac disease: minireview article.
    Caputo I; D'Amato A; Troncone R; Auricchio S; Esposito C
    Amino Acids; 2004 Jul; 26(4):381-6. PubMed ID: 15290344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unexpected role of surface transglutaminase type II in celiac disease.
    Maiuri L; Ciacci C; Ricciardelli I; Vacca L; Raia V; Rispo A; Griffin M; Issekutz T; Quaratino S; Londei M
    Gastroenterology; 2005 Nov; 129(5):1400-13. PubMed ID: 16285941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of transglutaminase 2 enzymatic activity ameliorates the anti-angiogenic effects of coeliac disease autoantibodies.
    Caja S; Myrsky E; Korponay-Szabo IR; Nadalutti C; Sulic AM; Lavric M; Sblattero D; Marzari R; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
    Scand J Gastroenterol; 2010 Apr; 45(4):421-7. PubMed ID: 20095873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for anti-transglutaminase 2 autoantibodies in the pathogenesis of coeliac disease?
    Lindfors K; Kaukinen K; Mäki M
    Amino Acids; 2009 Apr; 36(4):685-91. PubMed ID: 18594945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiac disease: from pathogenesis to novel therapies.
    Schuppan D; Junker Y; Barisani D
    Gastroenterology; 2009 Dec; 137(6):1912-33. PubMed ID: 19766641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis of autoimmune diseases: antibodies against transglutaminase, peptidylarginine deiminase and protein-bound citrulline in primary Sjögren's syndrome, multiple sclerosis and Alzheimer's disease.
    Bodil Roth E; Theander E; Londos E; Sandberg-Wollheim M; Larsson A; Sjöberg K; Stenberg P
    Scand J Immunol; 2008 Jun; 67(6):626-31. PubMed ID: 18476880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The function of tissue transglutaminase in celiac disease.
    Di Sabatino A; Vanoli A; Giuffrida P; Luinetti O; Solcia E; Corazza GR
    Autoimmun Rev; 2012 Aug; 11(10):746-53. PubMed ID: 22326684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease.
    Vetrano S; Zampaletta U; Anania MC; Di Tola M; Sabbatella L; Passarelli F; Maffia C; Sanjust MG; Lettieri F; De Pità O; Picarelli A
    Dig Liver Dis; 2007 Oct; 39(10):911-6. PubMed ID: 17719860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the immune response against tissue transglutaminase in the pathogenesis of coeliac disease.
    Freitag T; Schulze-Koops H; Niedobitek G; Melino G; Schuppan D
    Autoimmun Rev; 2004 Feb; 3(2):13-20. PubMed ID: 15003183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
    Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross linking to tissue transglutaminase and collagen favours gliadin toxicity in coeliac disease.
    Dieterich W; Esslinger B; Trapp D; Hahn E; Huff T; Seilmeier W; Wieser H; Schuppan D
    Gut; 2006 Apr; 55(4):478-84. PubMed ID: 16188922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies in celiac disease.
    Alaedini A; Green PH
    Autoimmunity; 2008 Feb; 41(1):19-26. PubMed ID: 18176861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic associations and immunopathogenesis of coeliac disease.
    Pécsi G
    Acta Physiol Hung; 2000; 87(4):339-53. PubMed ID: 11732888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 Transglutaminase in Coeliac Disease: A Key Player in Pathogenesis, Diagnosis and Therapy.
    Paolella G; Sposito S; Romanelli AM; Caputo I
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and characterization of circulating tissue transglutaminase-specific T cells in coeliac disease.
    Ciccocioppo R; Finamore A; Mengheri E; Millimaggi D; Esslinger B; Dieterich W; Papola F; Colangeli S; Tombolino V; Schuppan D; Corazza GR
    Int J Immunopathol Pharmacol; 2010; 23(1):179-91. PubMed ID: 20377989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminases in inflammation and fibrosis of the gastrointestinal tract and the liver.
    Elli L; Bergamini CM; Bardella MT; Schuppan D
    Dig Liver Dis; 2009 Aug; 41(8):541-50. PubMed ID: 19195940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.